Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
MRI · 1 trial · 1 indication
MRI test
MRI test
| Arm | Type | Description |
|---|---|---|
| Healthy Volunteer | OTHER | Healthy Volunteer cohort |
| Heart Failure | OTHER | Heart Failure cohort |
| Name | Type | Description |
|---|---|---|
| MRI | PROCEDURE | MRI of lungs to measure lung water content before and after passive leg raising (PLR) |
Inclusion Criteria: * Heart Failure Patients: * Established diagnosis of mild to moderate heart failure of any aetiology with symptoms defined as corresponding to the New York Heart Association (NYHA) class I, II or III * Able in the opinion of the patient and investigator to be supine for 1 hour a...
MRI is an investigational imaging technique being studied for use in Heart Failure, Congestive. It is being evaluated in a Phase 1 clinical trial to measure lung water with posture changes in patients with cardiac failure and healthy volunteers. The study is completed and enrolled 20 participants in the United Kingdom.
MRI is being developed by GSK plc, a pharmaceutical company traded on the stock exchange under the ticker GSK. The company is conducting clinical research on this imaging technique for cardiovascular applications, specifically in the area of congestive heart failure.
MRI is in Phase 1 clinical development. It has completed one Phase 1 trial with 20 participants. The trial was a controlled study, not randomized or double-blind, and included healthy volunteers as well as patients with congestive heart failure. The study took place in the United Kingdom.
MRI has one completed clinical trial registered as NCT01277679, titled 'Evaluation of MRI Measures of Lung Water With Posture Changes in Healthy Volunteers and in Patients With Cardiac Failure.' This Phase 1 study enrolled 20 participants with congestive heart failure and healthy volunteers in the United Kingdom.
MRI is not FDA approved. It is an investigational imaging technique currently in Phase 1 clinical development for congestive heart failure. The only completed trial was a small controlled study of 20 participants in the United Kingdom, and it remains in early-stage clinical research.